Condition: Diabetic Foot Ulcer · Osteomyelitis Chronic · Sponsor: The University of Texas Health Science Center at San Antonio
This study is being done to collect data from treatment of patients who have diabetes with non-healing foot wounds and are being treated with a resorbable and biocompatible borate-based bioactive glass fiber matrix. A borate-based bioactive glass fiber matrix is used to cover the ulcer for wound management. The primary objective of this study is to evaluate the safety and efficacy of the borate-based bioactive glass fiber matrix in the treatment of diabetic foot ulcers in a real-world setting. The secondary objective is to evaluate the clinical and financial benefits in terms of quality of healing, pain, and treatment cost.
This description comes directly from the study's public registry record.
Arthur Tarricone, DPM · 210-567-7000 · tarricone@uthscsa.edu
Nicholas Lucio · 210-567-4624 · luciond@uthscsa.edu
Always discuss trial participation with your own doctor first.
| UT Health Medical Arts and Research Center | San Antonio, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06598241